Clinical N Nature Medicine
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Clinical N Nature Medicine
Clinical N Nature Medicine
Clinical N Nature Medicine
Software N Nature Medicine
Software
GEN
Using cryo-EM and an AI-designed scaffold, researchers mapped how Andes hantavirus engages a receptor on human cells. The findings explain how antibodies block attachment and may highlight a potential target for antiviral development. The post Cryo-EM and AI-Designed Scaffold Rev…
Software W Weekly Tech+Bio
It seems the sentiment has shifted from platform pitches to what there is in the clinical pipeline...
Agriculture
CropLife
The newly named President, North America Crop Protection, discussed market dynamics, biologicals, and the industry’s future with CropLife at Syngenta’s Media Summit. The post CropLife on the Road: One-on-One with Syngenta’s Jeff Cecil appeared first on CropLife.
Agriculture
AgriBusiness Global
As the global biologicals community gathered in Basel, several clear trends emerged, offering a roadmap for the industry's next phase of growth and innovation. The post AgriBusiness Global on the Road: What’s Trending at ABIM 2026 appeared first on AgriBusiness Global.
Industry
MedTech Dive
The testing company believes an unauthorized third party accessed patient records.
Industry
Fierce Biotech
Looking Beyond the First Answer Towards Delivering Impact dwunderlin Thu, 10/22/2026 - 16:17
Manufacturing B BioProcess International
The Lone Star State will host one of ten planned facilities in the US by the pharmaceutical conglomerate.
Clinical B BioPharm International
Rohit Tripathi, vice president of industry strategy, consumer packaged goods, and manufacturing at RELEX Solutions, explains where cold-chain planning still breaks down and why biopharma supply chain leaders should use AI to act on data sooner, with humans making the final call.
Regulatory B BioPharm International
The FDA grants accelerated approval to Ultomiris for IgA nephropathy, Alcon acquires Neurotech and its MacTel cell therapy for $550 million, and BioNTech and Bristol Myers Squibb add Trodelvy to a phase 3 trial in triple-negative breast cancer.
Clinical A Applied Clinical Trials
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Industry
BioPharma Dive
A combination of the shot and the immunotherapy Keytruda cut the risk of relapse or death by 42% in a landmark melanoma study that met Wall Street expectations but triggered a “sell-the-news reaction,” one analyst wrote.
Clinical
STAT Biotech
A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to standard treatment.
Regulatory
Drug Delivery Business
After obtaining U.S. and European approvals this summer, Enable Injections has claimed its first regulatory green light in Japan for its enFuse wearable drug delivery technology. The country’s Ministry of Health, Labour and Welfare approved Sanofi’s push-button CirCLIQ Injector f…
Software
TechCrunch Biotech and Health
Microsoft’s new AI diagnostic system beat generalist doctors on hard cases, according to a study in Science. But most of the improvement seems to come from the AI models underneath, not from Microsoft’s system itself.
Software
Inside Precision Medicine
A "personal health agent" powered by artificial intelligence has been created that can analyze health data collected on wearables and combine it with an individual’s medical information and broader clinical knowledge to give personalized health advice. The post Next-Generation AI…
Industry
TechCrunch Biotech and Health
Wearing cameras and sensor gloves, the startup’s human chemists will train robots to perform various lab tasks.
Research
Fierce Biotech
Connected clinical research: from fragmentation to progress pesurya Thu, 10/22/2026 - 14:35
Funding
GEN
EQT has €354 billion in assets under management and a three-decade track record of acquiring, developing, and sometimes selling companies that include life sciences tools/tech concerns. The post EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private a…
Clinical
Fierce Pharma
Beyond Reimbursements: Uniting Patient Payments & Travel Logistics to Drive Trial Performance scox Thu, 10/22/2026 - 14:30 Wed, 12/09/2026 - 11:00 Resource Type Webinar Michael Tucker - Moderator Dave Bjork Ashley Hopkins Chelsey Ryan What if you could increase patient screen…
Clinical
Fierce Biotech
Beyond Reimbursements: Uniting Patient Payments & Travel Logistics to Drive Trial Performance scox Thu, 10/22/2026 - 14:30 Wed, 12/09/2026 - 11:00 Resource Type Webinar Michael Tucker - Moderator Dave Bjork Ashley Hopkins Chelsey Ryan What if you could increase patient screen…
Industry
GEN
The results of a large prospective proteomic study have associated proteins linked with the immune system, cell adhesion, blood vessel formation, and known prostate cancer genes, to future risk of developing prostate cancer, including aggressive disease. The post Proteins Circula…
Clinical
STAT Biotech
AbbVie's lutikizumab, an experimental therapy for a chronic skin condition, succeeded in a late-stage trial but missed market expectations.
Industry V Virological
Alvin Crespo-Bellido1, Jennifer L. Havens1, Thomas P. Peacock2,3, Florence Débarre4, Martha I. Nelson1 1 Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD USA 2 The Pirbright Institute, Woking, UK 3Department of Infectious…
Industry
Fierce Biotech
BioNTech Each person’s cancer is unique – and we’re built for that. BioNTech is translating groundbreaking science into medicines to treat the full continuum of cancer. So you can find your patients a treatment option that’s right for them. dwunderlin Thu, 10/22/2026 - 14:18 Each…
Clinical A Applied Clinical Trials
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction…
Funding
MedCity News
Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a majority stake in Aurion Biotech, a startup developing a corneal cell therapy. The post Alcon Expan…
Software
GEN
RFD4-Proteina is an open model based on Nvidia’s NVIDIA BioNeMo™ artificial intelligence (AI) platform for chemistry and biology that combines programmable protein design with search capabilities. RFD4-Proteina generates targeted protein designs, enabling scientists and agents to…
Industry
Bio.News
Patient advocates are no strangers to the sometimes painful challenges of promoting access to medicines and treatments. The key, they say, is staying two […] The post PACE: Pushing past the pain to achieve access for the 21st Century appeared first on Bio.News.
Software
GEN
A year-long collaboration involving scientists at PerturbAI, OpenAI, and their other institutions yielded an AI reasoning framework that turns datasets into testable hypotheses, with thousands of agents analyzing whole-brain genomic data in minutes instead of months. The post Per…
Regulatory P Pharmaceutical Executive
FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI Proteins’ collaboration with Astellas, and Incubate’s John Stanford on which therapeutic areas MFN deals might…
Regulatory
FDA Press Announcements
FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments.
Industry
GEN
ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address emphasizing hope, leadership, and the importance of communication amid the challenges facing science today. The post ASHG President Susan Slaugenhaupt Calls for Hope, Leadership…
Manufacturing
Pharmaceutical Technology
At CPHI Milan 2026, pharma leaders examined how AI can accelerate formulation, process development, maintenance, and quality management—without compromising data security or human oversight.
Funding
Inside Precision Medicine
Europe’s biotechnology sector has world-class science, but turning discoveries into globally competitive companies remains a challenge. Reporting from Nordic Life Science Days in Stockholm, Inside Precision Medicine explores the funding gaps, development expertise, regulatory ref…
Regulatory
BioPharma Dive
U.S. regulators have accepted a new submission for Vyglxia, offering the chance at a turnaround for another rare disease medicine spurned by previous FDA leadership.
Clinical
Bio.News
Patient advocacy is often a long game, so it is important to remember (and celebrate) the home runs as the hits come—and keep on […] The post Patient advocates launch PACE by reviewing their big hits in 2026 appeared first on Bio.News.